Sclerotherapy with bleomycin using image guidance

PDF download is not available for Arabic and Urdu languages at this time. Please use the browser print function instead.

Learn how bleomycin is used in sclerotherapy to treat vascular malformations. Find information about the advantages of using bleomycin as well as any risks involved and precautions to be considered.

Key points

  • Sclerotherapy is used to treat vascular malformations. The sclerosant is injected into the vascular malformation by an interventional radiologist to shrink the malformed blood vessels.
  • Bleomycin is a sclerosant that can be used for sclerotherapy for lymphatic and venous malformations.
  • Bleomycin is associated with less swelling than other sclerosants.
  • Using bleomycin for sclerotherapy is usually considered a low risk procedure.
  • Patients who have had bleomycin treatment need to get a yearly health assessment by their primary care physician.
  • A chest X-ray will need to be done one to two years following the completion of bleomycin treatment.
Last updated: August 4th 2017